Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in Glioma.

Biomolecules - 6 Mar 2024

Qin Xuhui, Wang Bing, Lu Xia, Song Yanyang, Wang Wei

Abstract excerpt

Gliomas, the most prevalent and lethal form of brain cancer, are known to exhibit metabolic alterations that facilitate tumor growth, invasion, and resistance to therapies. Peroxisomes, essential organelles responsible for fatty acid oxidation and reactive oxygen species (ROS) homeostasis, rely on the receptor PEX5 for the import of metabolic enzymes into their matrix. However, the prognostic significance of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Peroxisome-Targeting Signal 1 Receptor

Share to Prognosis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 38540734
DOI: 10.3390/biom14030314
PMCID: PMC10967733

Genes

PEX5
GSTK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in Glioma.PMID 38540734Read ↗

Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in GliomaSemantic proximity Read ↗

Identification of COX5B as a novel biomarker in high-grade glioma patientsSemantic proximity Read ↗

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in gliomaSemantic proximity Read ↗

SLC1A5 Enhances Malignant Phenotypes Through Modulating Ferroptosis Status and Immune Microenvironment in GliomaSemantic proximity Read ↗

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verificationSemantic proximity Read ↗

Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.Semantic proximity Read ↗

FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signalingSemantic proximity Read ↗

FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signalingSemantic proximity Read ↗

A Prognostic lncRNA Signature Associated with Lipid Metabolism in GliomaSemantic proximity Read ↗

FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cellsSemantic proximity Read ↗

A pan-cancer analysis has uncovered CCDC58, a mitochondrial gene associated with epilepsy, as a potential prognostic and immunotherapeutic biomarker for various cancer types, including gliomasSemantic proximity Read ↗

FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.